Interleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10
Authors:
- Hélio GaldinoHGHélio Galdino
- Anetícia Eduarda MaldanerAMAnetícia Eduarda Maldaner
- Lívia Lara PessoniLPLívia Lara Pessoni
- Frederico M SorianiFSFrederico M Soriani
- Ledice Inácia de Araújo PereiraLPLedice Inácia de Araújo Pereira
- Sebastião Alves PintoSPSebastião Alves Pinto
- Fernanda Bugalho DuarteFDFernanda Bugalho Duarte
- Clayson Moura GomesCGClayson Moura Gomes
- Anna Karoline Aguiar FleuriAFAnna Karoline Aguiar Fleuri
- Miriam Leandro DortaMDMiriam Leandro Dorta
- Milton Adriano Pelli de OliveiraMOMilton Adriano Pelli de Oliveira
- Mauro Martins TeixeiraMTMauro Martins Teixeira
Open Access
- 9 May 2014
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 1-13
Abstract
The interleukin 32 (IL-32) is a proinflammatory cytokine produced by immune and non-immune cells. It can be induced during bacterial and viral infections, but its production was never investigated in protozoan infections. American Tegumentary Leishmaniasis (ATL) is caused by Leishmania protozoan leading to cutaneous, nasal or oral lesions. The aim of this study was to evaluate the expression of IL-32 in cutaneous and mucosal lesions as well as in peripheral blood mononuclear cells (PBMC) exposed to Leishmania (Viannia) braziliensis. IL-32, tumour necrosis factor (TNF) and IL-10 protein expression was evaluated by immunohistochemistry in cutaneous, mucosal lesions and compared to healthy specimens. The isoforms of IL-32α, β, δ, γ mRNA, TNF mRNA and IL-10 mRNA were assessed by qPCR in tissue biopsies of lesions and healthy skin and mucosa. In addition, PBMC from healthy donors were cultured with amastigotes of L. (V.) braziliensis. In lesions, the parasite subgenus was identified by PCR-RFLP. We showed that the mRNA expression of IL-32, in particular IL-32γ was similarly up-regulated in lesions of cutaneous (CL) or mucosal (ML) leishmaniasis patients. IL-32 protein was produced by epithelial, endothelial, mononuclear cells and giant cells. The IL-32 protein expression was associated with TNF in ML but not in CL. IL-32 was not associated with IL-10 in both CL and ML. Expression of TNF mRNA was higher in ML than in CL lesions, however levels of IL-10 mRNA were similar in both clinical forms. In all lesions in which the parasite was detected, L. (Viannia) subgenus was identified. Interestingly, L. (V.) braziliensis induced only IL-32γ mRNA expression in PBMC from healthy individuals. These data suggest that IL-32 plays a major role in the inflammatory process caused by L. (Viannia) sp or that IL-32 is crucial for controlling the L. (Viannia) sp infection.Keywords
This publication has 62 references indexed in Scilit:
- NOD2 triggers an interleukin-32–dependent human dendritic cell program in leprosyNature Medicine, 2012
- IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung diseaseInternational Immunology, 2011
- Inflammation-dependent secretion and splicing of IL-32γ in rheumatoid arthritisProceedings of the National Academy of Sciences, 2011
- Paradoxical effects of constitutive human IL-32γ in transgenic mice during experimental colitisProceedings of the National Academy of Sciences, 2010
- A proinflammatory cytokine interleukin‐32β promotes the production of an anti‐inflammatory cytokine interleukin‐10Immunology, 2009
- Interleukin-32 Positively Regulates Radiation-Induced Vascular InflammationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Identification of the most active interleukin‐32 isoformImmunology, 2009
- Can interferon-γ and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?Clinical and Experimental Immunology, 2007
- Epithelial overexpression of interleukin-32α in inflammatory bowel diseaseClinical and Experimental Immunology, 2007
- The highways and byways of mRNA decayNature Reviews Molecular Cell Biology, 2007